Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...

The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...

Dr Willie told Reach: “You should speak to your doctor about any conditions or medications before taking any weight loss ...

Under the deal, cash-paying patients can access a month’s supply of Wegovy through the Danish drugmaker’s Novocare pharmacy for $299. The one-time price will also be available through Novo’s other ...

Patients have reported being hospitalised with inflammation of the pancreas suspected to be related to medicines such as ...

Eli Lilly edges ahead of Novo Nordisk as the stronger obesity bet, backed by robust sales growth, pipeline depth and ...

GIRLS actress Jenny Mollen has revealed she was rushed to hospital following a terrifying reaction to a fat-dissolving ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

MHRA launches genetic study into GLP-1 drug risks as Spain investigates Novo Nordisk for potential advertising violations.

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...